Contraceptive Provision to Adolescent Females Prescribed Teratogenic Medications
- PMID: 26676050
- DOI: 10.1542/peds.2015-1454
Contraceptive Provision to Adolescent Females Prescribed Teratogenic Medications
Abstract
Background and objectives: Rates of adult women receiving contraceptive provision when simultaneously prescribed a known teratogen are alarmingly low. The prevalence of this behavior among pediatric providers and their adolescent patients is unknown. The objective of this study was to describe pediatric provider behaviors for prescribing teratogens concurrently with counseling, referral, and/or prescribing of contraception (collectively called contraceptive provision) in the adolescent population.
Methods: A retrospective review was conducted examining visits in 2008-2012 by adolescents aged 14 to 25 years in which a known teratogen (US Food and Drug Administration pregnancy risk category D or X) was prescribed. The electronic medical records were queried for demographic information, evidence of contraceptive provision, and menstrual and sexual histories. The data were analyzed using standard statistical methods.
Results: Within 4172 clinic visits, 1694 females received 4506 prescriptions for teratogenic medications. The most commonly prescribed teratogens were topiramate, methotrexate, diazepam, isotretinoin, and enalapril. The subspecialties prescribing teratogens most frequently were neurology, hematology-oncology, and dermatology. Overall, contraceptive provision was documented in 28.6% of the visits. Whites versus nonwhites and older versus younger girls were more likely to receive contraceptive provision. The presence of a federal risk mitigation system for the teratogen also increased the likelihood of contraceptive provision.
Conclusions: Our data demonstrate female adolescents prescribed teratogens receive inadequate contraception provision, which could increase their risk for negative pregnancy outcomes. Although the presence of a federal risk mitigation system appears to improve contraceptive provision, these systems are costly and, in some instances, difficult to implement. Efforts to improve provider practices are needed.
Copyright © 2016 by the American Academy of Pediatrics.
Comment in
-
All Adolescents Deserve Routine Conversations About Sexual Activity and Pregnancy Prevention.Pediatrics. 2016 Jan;137(1). doi: 10.1542/peds.2015-3826. Epub 2015 Dec 16. Pediatrics. 2016. PMID: 26676051 No abstract available.
-
Young Women Prescribed Teratogenic Medications Are Often Not Provided with Contraceptives.Perspect Sex Reprod Health. 2016 Jun;48(2):104. doi: 10.1363/48e9616. Perspect Sex Reprod Health. 2016. PMID: 27303869 No abstract available.
Similar articles
-
Prescription of teratogenic medications in United States ambulatory practices.Am J Med. 2005 Nov;118(11):1240-9. doi: 10.1016/j.amjmed.2005.02.029. Am J Med. 2005. PMID: 16271908
-
Teratogenic medications and concurrent contraceptive use in women of childbearing ability with epilepsy.Epilepsy Behav. 2015 Nov;52(Pt A):212-7. doi: 10.1016/j.yebeh.2015.08.004. Epub 2015 Nov 6. Epilepsy Behav. 2015. PMID: 26460786
-
High-Risk Medication Prescriptions in Primary Care for Women Without Documented Contraception.J Am Board Fam Med. 2019 Jul-Aug;32(4):474-480. doi: 10.3122/jabfm.2019.04.180281. J Am Board Fam Med. 2019. PMID: 31300567
-
"Be smart, be safe, be sure". The revised Pregnancy Prevention Program for women on isotretinoin.J Reprod Med. 2001 Feb;46(2 Suppl):179-85. J Reprod Med. 2001. PMID: 11255826 Review.
-
Emergency contraception: a second chance at preventing adolescent unintended pregnancy.Curr Opin Pediatr. 1997 Aug;9(4):300-9. Curr Opin Pediatr. 1997. PMID: 9300185 Review.
Cited by
-
Contraceptive counselling and uptake of contraception among women with cardiovascular diseases: a systematic review and meta-analysis.Clin Res Cardiol. 2024 Aug;113(8):1151-1170. doi: 10.1007/s00392-024-02472-9. Epub 2024 Jul 10. Clin Res Cardiol. 2024. PMID: 38985159 Free PMC article. Review.
-
Feasibility of a Contraception Intervention for Hospitalized Adolescents and Young Adults.Hosp Pediatr. 2023 Apr 1;13(4):337-344. doi: 10.1542/hpeds.2022-006996. Hosp Pediatr. 2023. PMID: 36897226 Free PMC article.
-
Pediatric hematology providers' contraceptive practices for female adolescents and young adults with sickle cell disease: A national survey.Pediatr Blood Cancer. 2022 Oct;69(10):e29877. doi: 10.1002/pbc.29877. Epub 2022 Jul 20. Pediatr Blood Cancer. 2022. PMID: 35856776 Free PMC article.
-
Sexual Health Behaviors and Pregnancy Risk Among Hospitalized Female Adolescents.Hosp Pediatr. 2021 Oct;11(10):1129-1136. doi: 10.1542/hpeds.2021-005810. Epub 2021 Sep 13. Hosp Pediatr. 2021. PMID: 34518336 Free PMC article.
-
Clinical pearl: Expanding knowledge of emergency contraception among dermatologists.Int J Womens Dermatol. 2020 Jun 30;6(5):450-451. doi: 10.1016/j.ijwd.2020.06.010. eCollection 2020 Dec. Int J Womens Dermatol. 2020. PMID: 33898718 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
